Literature DB >> 20620917

International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010.

Mandeep R Mehra1, Maria G Crespo-Leiro, Anne Dipchand, Stephan M Ensminger, Nicola E Hiemann, Jon A Kobashigawa, Joren Madsen, Jayan Parameshwar, Randall C Starling, Patricia A Uber.   

Abstract

The development of cardiac allograft vasculopathy remains the Achilles heel of cardiac transplantation. Unfortunately, the definitions of cardiac allograft vasculopathy are diverse, and there are no uniform international standards for the nomenclature of this entity. This consensus document, commissioned by the International Society of Heart and Lung Transplantation Board, is based on best evidence and clinical consensus derived from critical analysis of available information pertaining to angiography, intravascular ultrasound imaging, microvascular function, cardiac allograft histology, circulating immune markers, non-invasive imaging tests, and gene-based and protein-based biomarkers. This document represents a working formulation for an international nomenclature of cardiac allograft vasculopathy, similar to the development of the system for adjudication of cardiac allograft rejection by histology.

Entities:  

Mesh:

Year:  2010        PMID: 20620917     DOI: 10.1016/j.healun.2010.05.017

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  144 in total

1.  Everolimus-Eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy: the CART (Cardiac Allograft Reparative Therapy) Prospective Multicenter Pilot Study.

Authors:  Michele Pighi; Fabrizio Tomai; Alessandro Petrolini; Leonardo de Luca; Giuseppe Tarantini; Alberto Barioli; Paola Colombo; Silvio Klugmann; Marco Ferlini; Maurizio Ferrario Ormezzano; Bruno Loi; Paolo Calabrò; Renato Maria Bianchi; Giuseppe Faggian; Alberto Forni; Corrado Vassanelli; Marco Valgimigli; Flavio Ribichini
Journal:  J Cardiovasc Transl Res       Date:  2015-12-18       Impact factor: 4.132

Review 2.  Imaging in patients after cardiac transplantation and in patients with ventricular assist devices.

Authors:  Bhanu Gupta; Dany Jacob; Randall Thompson
Journal:  J Nucl Cardiol       Date:  2015-04-02       Impact factor: 5.952

3.  Myocardial Fibrosis and Prognosis in Heart Transplant Recipients.

Authors:  Andrew Hughes; Osama Okasha; Afshin Farzaneh-Far; Felipe Kazmirczak; Prabhjot S Nijjar; Pratik Velangi; Mehmet Akçakaya; Cindy M Martin; Chetan Shenoy
Journal:  Circ Cardiovasc Imaging       Date:  2019-10-15       Impact factor: 7.792

4.  Elevated serum vascular endothelial growth factor and development of cardiac allograft vasculopathy in children.

Authors:  Kae Watanabe; Anis Karimpour-Fard; Alix Michael; Shelley D Miyamoto; Stephanie J Nakano
Journal:  J Heart Lung Transplant       Date:  2018-04-30       Impact factor: 10.247

5.  Myocardial perfusion reserve and global longitudinal strain as potential markers of coronary allograft vasculopathy in late-stage orthotopic heart transplantation.

Authors:  Akhil Narang; John E Blair; Mita B Patel; Victor Mor-Avi; Savitri E Fedson; Nir Uriel; Roberto M Lang; Amit R Patel
Journal:  Int J Cardiovasc Imaging       Date:  2018-05-04       Impact factor: 2.357

6.  Donor-specific antibodies to class II antigens are associated with accelerated cardiac allograft vasculopathy: a three-dimensional volumetric intravascular ultrasound study.

Authors:  Yan Topilsky; Manish J Gandhi; Tal Hasin; Laurie L Voit; Eugenia Raichlin; Barry A Boilson; John A Schirger; Brooks S Edwards; Alfredo L Clavell; Richard J Rodeheffer; Robert P Frantz; Sudhir S Kushwaha; Amir Lerman; Naveen L Pereira
Journal:  Transplantation       Date:  2013-01-27       Impact factor: 4.939

7.  Alloantibody and complement promote T cell-mediated cardiac allograft vasculopathy through noncanonical nuclear factor-κB signaling in endothelial cells.

Authors:  Dan Jane-Wit; Thomas D Manes; Tai Yi; Lingfeng Qin; Pamela Clark; Nancy C Kirkiles-Smith; Parwiz Abrahimi; Julie Devalliere; Gilbert Moeckel; Sanjay Kulkarni; George Tellides; Jordan S Pober
Journal:  Circulation       Date:  2013-09-17       Impact factor: 29.690

8.  Dual-source cardiac computed tomography angiography (CCTA) in the follow-up of cardiac transplant: comparison of image quality and radiation dose using three different imaging protocols.

Authors:  D Beitzke; V Berger-Kulemann; V Schöpf; S Unterhumer; E Spitzer; G M Feuchtner; M Gyöngyösi; K Uyanik-Uenal; A Zuckermann; C Loewe; F Wolf
Journal:  Eur Radiol       Date:  2015-04-26       Impact factor: 5.315

Review 9.  Coronary cardiac allograft vasculopathy versus native atherosclerosis: difficulties in classification.

Authors:  Annalisa Angelini; Chiara Castellani; Marny Fedrigo; Onno J de Boer; Lorine B Meijer-Jorna; Xiaofei Li; Marialuisa Valente; Gaetano Thiene; Allard C van der Wal
Journal:  Virchows Arch       Date:  2014-05-08       Impact factor: 4.064

10.  Erythroblast transformation-specific 2 correlates with vascular smooth muscle cell apoptosis in rat heterotopic heart transplantation model.

Authors:  Xiaojuan Liu; Daliang Yan; Yangcheng Li; Xilin Sha; Kunpeng Wu; Jianhua Zhao; Chen Yang; Chao Zhang; Jiahai Shi; Xiang Wu
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.